NCT04989101View on ClinicalTrials.gov

Nigelle 5 in Prevention of Influanza

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 5, 2021

Primary Completion Date

July 31, 2021

Study Completion Date

August 31, 2021

Conditions
COVID-19 Acute Respiratory Distress Syndrome
Interventions
DRUG

Nigella

The candidate must take one capsule / day of nigella 5 for 21 days (1 bottle). Follow-up should be done weekly for 1 month.

Trial Locations (1)

4054

HU Sahloul, sousse, Tunisia, Sousse

All Listed Sponsors
lead

Hôpital Universitaire Sahloul

OTHER